DGX Quest Diagnostics: שווי הפעילות העסקית

Quest Diagnostics (DGX) leverages robotic IT centers to reduce costs when processing millions of tests. The company minimizes risks through a broad service portfolio, ranging from basic screenings to complex genetics and support for pharmaceutical behemoths. The current enterprise value is 32616.13. This chart of share price quotes demonstrates the price action of this medical diagnostics market player.

Enterprise Value combines market capitalization with net debt, determining the total buyout price of a business regardless of short-term market fluctuations. For Quest Diagnostics (DGX), this metric reflects the value of a capital-intensive network of laboratories and IT hubs, where robotics efficiency reduces unit costs; the trend of the current EV allows for an assessment of how closely the fundamental value of the infrastructure aligns with market expectations.